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Many studies have shown that the estrogen in oral hormonal contraceptives (HC) increases serum 25-
hydroxyvitamin D 25(OH)D concentrations in women. As a hormone that regulates gene transcription 
estrogen is known to increase Vitamin-D binding protein concentrations, and therefore 25(OH)D 
concentrations in the blood. Furthermore, Vitamin D is a major regulator of bone metabolism and its 
status within the blood influences circulating levels of bone turnover markers. The objective of this study 
was to determine the effects of HC use on serum 25OHD concentrations and biochemical markers of bone 
turnover in active young females. Thirty-nine young (age 18-33 years), active (≥5 h of aerobic exercise 
per week) women participated (HC users, n=16; Non-users, n=23). Of the HC users, 9 were taking 
monophasic HC; 7 were taking triphasic HC. Fasting serum samples were taken during the early follicular 
phase (d2-5 of the menstrual cycle) and were analyzed for 25OHD and biochemical bone markers [bone 
alkaline phosphatase (BAP), N-telopeptide of collagen cross-links (NTx), parathyroid hormone (PTH) 
and osteocalcin (OC)] using radioimmuno assay and ELISA, respectively. Serum 25OHD was 
significantly greater (p=.007) and BAP significantly lower (p=.002) in HC users compared with nonusers. 
No differences were found between groups for NTx, PTH or osteocalcin. Serum concentrations of BAP 
and Vitamin D were negatively correlated (r= -.453; p=.004). We conclude that HC use is associated with 
increased serum 25OHD concentrations and lower circulating BAP in young active females.  
 
